Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
about
Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesisIsolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3Vascular endothelial growth factor (VEGF)-D and VEGF-A differentially regulate KDR-mediated signaling and biological function in vascular endothelial cellsHuman vascular endothelial growth factor B: characterization of recombinant isoforms and generation of neutralizing monoclonal antibodiesThe lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseasesVascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinomaPlasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-DLymphatic endothelium: morphological, molecular and functional propertiesVascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cellsMolecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants.Lymphangiogenesis and Lesion Heterogeneity in Interstitial Lung DiseasesLymphatic Vessels, Inflammation, and Immunity in Skin CancerThe cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysisCorneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)Pharmacological aspects of Vipera xantina palestinae venomNovel molecular pathways in Gorham disease: implications for treatmentThe crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolutionDeciphering Pro-Lymphangiogenic Programs during Mammary Involution and Postpartum Breast CancerBeta-catenin inversely regulates vascular endothelial growth factor-D mRNA stabilityVEGF-C mediates cyclic pressure-induced endothelial cell proliferationCorrelation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomasVascular endothelial growth factor D is dispensable for development of the lymphatic system.VEGF-D expression and lymph vessels play an important role for lymph node metastasis in papillary thyroid carcinomaGenetic background of HSH in three Polish families and a patient with an X;9 translocationDoxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasisVascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryosCharacterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2NFATc1 regulates lymphatic endothelial developmentLymphangiogenesis is required for pancreatic islet inflammation and diabetesElevated VEGF-D Modulates Tumor Inflammation and Reduces the Growth of Carcinogen-Induced Skin TumorsVEGF guides angiogenic sprouting utilizing endothelial tip cell filopodiaLymphatic vessel density and function in experimental bladder cancer.Blood vessel endothelial VEGFR-2 delays lymphangiogenesis: an endogenous trapping mechanism links lymph- and angiogenesis.Macrophages regulate corpus luteum development during embryo implantation in mice.Cloning, expression, characterization, and role in autocrine cell growth of cell surface retention sequence binding protein-1.Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cellsExpression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors. VEGF D and flt-4t(Delta773-1081) overexpression is diagnostic for sentinel lymph node metastasis.Structure-function studies of two synthetic anti-vascular endothelial growth factor Fabs and comparison with the Avastin Fab.A 96-well format for a high-throughput baculovirus generation, fast titering and recombinant protein production in insect and mammalian cells.
P2860
Q22010852-475EDF59-4F21-4BD0-A999-BA0BE52507B8Q24291630-B2207756-C3CB-4C08-AC5A-FDAB292AEF63Q24297590-EB8C542D-90DE-4854-BDAF-688EF987478CQ24309240-C3BB3D5D-660A-41EB-AE5E-1D3640366EA8Q24538981-FD6CFDAB-21EA-417E-937C-9BA968882B4BQ24608283-EADA8967-1A49-4092-A7D5-5CC0F25AF44BQ24656802-A288BA29-D81C-47B1-BE8A-1078C22C131EQ24672582-A5181238-CC4D-475C-9319-A24950C93361Q24672687-1FEE5CAD-753B-4B39-84EA-83C78F1A659FQ24679724-AE262F33-4845-4545-8B64-57D5E334DEA8Q24801016-C0D82ED5-AC1B-4E99-ABC2-D21CDABAF119Q26773022-A93187BE-6F4F-4887-8475-959B9D61F252Q26778332-D12DF42C-0942-424C-A270-15D544121786Q26796921-36346602-CB2B-41C3-978A-EE0BB1B9D06AQ26823757-21554E2E-9AA2-47E4-BFA8-85418AA6EC59Q27005573-74E15B62-4189-455A-AF5A-8860F1F1DAABQ27005629-BE13BE92-1C5D-4278-B2F7-1C9064B528D1Q27628017-256E6345-C2A6-4ED8-943F-92E84A25ABA4Q28072448-1D9A3F38-9183-4757-AF29-9EB7569C9E27Q28201923-375CED7E-4507-438E-B89D-AD5440B6B78FQ28208643-A19BFF81-2C4F-49F9-A125-296AC8AF3FD5Q28211085-265DB0E5-47F1-419C-9B73-2C1C11405A39Q28237748-7D62B4A2-B399-4D75-AA88-E1303E106258Q28242925-004E49F6-9D3D-4B23-A5FC-124ABA5A3CC5Q28280168-A78B73B7-B0A1-4514-81A6-64382E571BA5Q28469047-059DFA95-637C-4023-8978-9830247C3747Q28506172-8F8E490A-54A6-4531-9C05-D88E7AF024EBQ28580820-5C79CAC2-A430-4601-8842-D285BDFB4BBEQ28593523-3FAE1EFA-34D8-4DEF-8102-0BBAF6F51DB1Q28742322-592AED8B-91D2-40CB-8FE4-457B64AC0E9FQ28829519-08394221-7B42-4B08-BF68-013F3772B4F0Q29617501-9DD5F2A6-5A77-4940-9A78-E7875FF35F86Q30481281-9EEFED81-F801-48CB-95EE-3244D5E1AD6DQ30498120-0373A721-FA66-4E4B-9201-6183B162F9CDQ30541876-188D0599-E01D-46FC-A158-57C9DA261F97Q30975700-6EAFE6D5-8853-4D03-8A07-E29942D177DFQ31079430-856A88A7-F005-4921-BDEF-569838B7B553Q33202253-CF523DA8-EF67-480C-A85C-21C9D38744B1Q33230191-1990AB88-4968-4B7A-997F-D79AAFD8B09AQ33434173-7D675B9B-0781-4079-B308-CCCBA8FF6CE1
P2860
Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Vascular endothelial growth fa ...... k1) and VEGF receptor 3 (Flt4)
@ast
Vascular endothelial growth fa ...... k1) and VEGF receptor 3 (Flt4)
@en
Vascular endothelial growth fa ...... k1) and VEGF receptor 3 (Flt4)
@en-gb
Vascular endothelial growth fa ...... k1) and VEGF receptor 3 (Flt4)
@nl
type
label
Vascular endothelial growth fa ...... k1) and VEGF receptor 3 (Flt4)
@ast
Vascular endothelial growth fa ...... k1) and VEGF receptor 3 (Flt4)
@en
Vascular endothelial growth fa ...... k1) and VEGF receptor 3 (Flt4)
@en-gb
Vascular endothelial growth fa ...... k1) and VEGF receptor 3 (Flt4)
@nl
prefLabel
Vascular endothelial growth fa ...... k1) and VEGF receptor 3 (Flt4)
@ast
Vascular endothelial growth fa ...... k1) and VEGF receptor 3 (Flt4)
@en
Vascular endothelial growth fa ...... k1) and VEGF receptor 3 (Flt4)
@en-gb
Vascular endothelial growth fa ...... k1) and VEGF receptor 3 (Flt4)
@nl
P2093
P2860
P50
P3181
P356
P1476
Vascular endothelial growth fa ...... k1) and VEGF receptor 3 (Flt4)
@en
P2093
P2860
P304
P3181
P356
10.1073/PNAS.95.2.548
P407
P577
1998-01-01T00:00:00Z